These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10719442)

  • 1. [Hyperhomocysteinemia and arterial or venous thrombosis. Retrospective study of 75 cases].
    Jacob N; Cacoub P; Hausfater P; Tazi Z; Hamidou S; Godeau P; Foglietti MJ; Piette JC
    Presse Med; 2000 Feb; 29(6):287-93. PubMed ID: 10719442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced risk of thrombotic disease in patients with acquired vitamin B12 and/or folate deficiency: role of hyperhomocysteinemia.
    Remacha AF; Souto JC; Rámila E; Perea G; Sarda MP; Fontcuberta J
    Ann Hematol; 2002 Nov; 81(11):616-21. PubMed ID: 12454698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
    Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
    Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.
    Saifan C; El-Charabaty E; El-Sayegh S
    Vasc Health Risk Manag; 2013; 9():361-4. PubMed ID: 23898227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels.
    Lijfering WM; Veeger NJ; Brouwer JL; van der Meer J
    Haematologica; 2007 Dec; 92(12):1703-6. PubMed ID: 18055997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine in vascular Behcet disease: a meta-analysis.
    La Regina M; Orlandini F; Prisco D; Dentali F
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2067-74. PubMed ID: 20634474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss.
    Nadir Y; Hoffman R; Brenner B
    Ann Hematol; 2007 Jan; 86(1):35-40. PubMed ID: 17043779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia and thrombosis.
    Makris M
    Clin Lab Haematol; 2000 Jun; 22(3):133-43. PubMed ID: 10931161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
    Willems HP; den Heijer M; Bos GM
    Semin Thromb Hemost; 2000; 26(3):297-304. PubMed ID: 11011847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma homocysteine levels in patients with ischemic heart disease].
    Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
    Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.